Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from GU and Thyroid cancer

  • You have access
    Somatostatin receptors expression in normal prostate gland assessed by 68Ga-DOTATOC PET/CT
    Mila Todorović-Tirnanić, Milan Gajić, Vladimir Obradović and Richard Baum
    Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 63;
  • You have access
    Synthesis and characterization of hypoxia trapping incorporated 177Lu-bombesin analogs for prostate cancer
    Zhengyuan Zhou, Nilesh Wagh, Wen Shi, Yinnong Jia, Susan Brusnahan and Jered Garrison
    Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 64;
  • You have access
    Imaging bladder cancer: Correlation with histopathologic findings
    Sushil Tripathi, Edouard Trabulsi, Pardeep Kumar, Ruth Birbe, Paolo Cotzia, Peter McCue, Charalambos Solomides, Leonard Gomella and Mathew Thakur
    Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 67;
  • You have access
    Baculovirus vector-mediated transfer of sodium iodide symporter and plasminogen kringle 5 genes for tumor radioiodide therapy
    Min Zhang, Rui Guo, Shuo Shi, Yin Miao and Biao Li
    Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 69;
  • You have access
    Radionuclide and fluorescence imaging of renal cell carcinoma using dual-label anti-Carbonic Anhydrase IX antibody G250
    Constantijn Muselaers, Mark Rijpkema, Desiree Bos, Johan Langenhuijsen, Peter Mulders, Egbert Oosterwijk, Wim Oyen and Otto Boerman
    Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 66;
  • You have access
    Inhibition of PI3K pathway induces differentiation of anaplastic thyroid cancer and attenuates self-renewal of cancer stem cells and consequently improves the effect of radioiodide therapy
    Chien-Chih Ke, Ya-Ju Hsieh, Luen Hwu and Ren-Shyan Liu
    Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 68;
  • You have access
    Cerenkov luminescence imaging for radiation dose estimation of a 90Y-labeled GRPr antagonist
    Christian Lohrmann, Hanwen Zhang, Daniel Thorek, Pat Zanzonico, Jacob Houghton, Pooja Desai, Christopher Irwin, Thomas Reiner, Jan Grimm and Wolfgang Weber
    Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 65;
SNMMI

© 2025 SNMMI

Powered by HighWire